Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Grifols threatens lawsuit against Gotham City over critical report

(Sharecast News) - The row between Grifols and Gotham City Research intensified on Wednesday when the Spanish drug company said it would take legal action against the short-seller fund over a critical report that wiped billions from the firm's value on Tuesday. Shares in Grifols made a slight recovery, trading almost 9% higher on Wednesday, after the firm said it would seek compensation for financial and reputational damage to the company and its shareholders. Gotham also revealed it had reduced its position.

The stock plunged by 42% on Tuesday before finishing the session down 26%. Grifols, which makes medicines with human blood plasma, was scheduled to hold a conference call with investors on Thursday.

Gotham City said Grifols "manipulates" its reported debt and earnings before interest, taxes, depreciation and amortisation artificially, thereby reducing its leverage ratio through "deceptive and incorrect" treatment of financial statements through transactions with a company related to the founding Grifols family which controls the group.

"Should our estimate of the Grifols' true leverage be correct, (it) will face notably higher financing costs. Consequently, we believe shares are uninvestable, likely zero," Gotham City said.

In response Grifols said the report was based on "false information" and denied all the allegations within it.

A separate filing to Spanish regulators on Wednesday revealed General Industrial Partners, a joint venture between hedge funds Gotham City Research and Portsea Asset Management, had cut its short position in Grifols GRLS.MC to 0.06% from 0.57%.

Reporting by Frank Prenesti for Sharecast.com

Share this article

Related Sharecast Articles

Agronomics investee Solar Foods raises EUR 8m
(Sharecast News) - Cellular agriculture investor Agronomics announced on Friday that its portfolio company Solar Foods had raised an additional €8m through Finnish investment organiser Springvest.
Berenberg hikes target price on Greggs
(Sharecast News) - Analysts at Berenberg raised their target price on bakery chain Greggs from 3,550.0p to 3,990.0p on Friday as it noted that customer appeal had broadened as its market share was expanding.
Thousands of UK firms fighting for survival - Begbies Traynor
(Sharecast News) - More than half a million UK business are fighting for survival, according to an industry research published on Friday, weighed down by the weak economy.
Thruvision FY24 adjusted underlying losses widen
(Sharecast News) - Security technology business Thruvision said on Friday that adjusted underlying losses had widened in FY24 as revenues fell.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.